Detalhe da pesquisa
1.
Elevated sortilin expression discriminates functional from non-functional neuroendocrine tumors and enables therapeutic targeting.
Front Endocrinol (Lausanne);
15: 1331231, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38694940
2.
Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms.
J Cancer Res Clin Oncol;
149(12): 10925-10933, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37318593
3.
Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Endocrinology;
148(8): 3887-99, 2007 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17525126